 |  | 
In this 28-page issue, NBJ offers a breakdown of 2007 U.S. supplement sales data by condition-specific category and provides a detailed analysis of supplement, over-the-counter (OTC) and prescription drug sales for the top 16 condition-specific segments, including cold/flu/immune, joint health, heart health and bone health.
EXCERPT FROM OVERVIEW:
The creation of the Dietary Supplement Health and Education Act (DSHEA) of 1994 opened the door—or, perhaps more aptly put, cracked the door—for supplement companies to be able to describe specific health benefits for various product categories. Since then, a stampede of supplement firms and ingredient suppliers have pushed forward with condition-specific marketing and product-development efforts aimed at providing more targeted value propositions to consumers looking for natural solutions to precise health needs, such as immune-system support or cholesterol management. After more than a decade of implementation, this trend shows no sign of abating and, today, one can walk into a health food store or other supplement retailer to find rows of products targeted to diabetes support, gut health or other specific health conditions.
Nutrition Business Journal began analyzing the U.S. supplement market according to condition-specific product purchases in 2001. This has allowed the industry to compare sales of dietary supplements against sales of prescription and over-the-counter (OTC) drugs, which are both inherently targeted and marketed to specific health conditions. It has also helped the industry gain a greater understanding of how the supplement industry is performing within the larger national healthcare arena and identify where there might be further opportunities for growth. For instance, although they currently own only a small slice of the diabetes health products market, nutrition firms have the potential to make significant inroads with innovative new products in this category.
Of course, estimating condition-specific supplement sales remains challenging. This is because many supplements are useful for more than one condition, and it cannot be known precisely why a person purchases a specific supplement. For instance, when consumers buy fish oil pills, are they doing it primarily to support their heart health or brain health? Or is it for other reasons? Since we began doing our condition-specific modeling, NBJ has addressed this issue by allocating a percentage of sales in each of our 113 product categories to particular conditions, based on our analysis of how and why these particular supplements are generally used. So, for example, 100% of glucosamine and chondroitin sales are slotted into the joint category because these products are primarily targeted to this condition. But, for a multi-use supplement such as psyllium, its 2007 sales have been divided among the heart, digestive, diabetes, anti-cancer and cold/flu/immune categories, based on our analysis of how psyllium is typically used by consumers.
Based on this analysis, NBJ estimates that the top 16 health conditions—which range from general health to vision health—accounted for 92% of U.S. supplement sales in 2007. Not including the sports/energy/weight-loss and general health categories (which, not surprisingly, make up the bulk of supplement purchases), the top three condition-specific categories tracked by NBJ are cold/flu/immune, joint health and heart health.
To continue reading, please order the issue below.
TABLE OF CONTENTS:
| Supplement and ingredient firms remain committed to health condition-specific products, which accounted for 92% of U.S. supplement sales in 2007. |
|
1 - 6 |
| NBJ’s Condition-Specific Category Analysis: We offer a breakdown of NBJ’s 2007 U.S. supplement sales data and a supplement, OTC and Rx market analysis for the top 16 condition-specific categories |
|
7 - 12 |
| Following a promising start that failed to materialize into full-blown success, LifeVantage Corp. aims for a sales comeback for its anti-aging pill, Protandim. |
|
13 - 15 |
The joint health category remains appealing to supplement and ingredient firms eager to fill the void created by recalled Rx joint drugs. |
|
16 - 17 |
Primus Pharmaceuticals takes medical food route to help osteoarthritis sufferers. |
|
18 |
No longer embarrassed to broach the subject of gut health, U.S. consumers fill up on probiotics and other digestive health aids. |
|
19 - 21 |
Hoping to claim their slice of the diabetes pie, nutrition firms court consumers with a growing range of blood-sugar management supplements and functional foods and beverages. |
|
22 - 24 |
Much work remains in U.S. battle against ‘diabesity,’ author Francine Kaufman, MD, says |
|
25 |
NBJ’s Stock Reporter: The U.S. economy taking its toll on many industry stocks. |
|
26 - 27 |
LIST OF FIGURES:
- U.S. Condition-Specific Markets Growth: 2000-2007
- U.S. Condition-Specific Supplements, OTC & Rx Revenues & Growth ($mil): 2007
- U.S. Condition-Specific Sales: 1999-2007
- $7.1 Billion U.S. Condition-Specific Cold/Flu/Immune Market in 2007
- $1.5 Billion Condition-Specific Heart Health Supplement Market in 2007
- U.S. Condition-Specific Brain Health/Mental Acuity Product Sales: 2003-2007
- $223 Million U.S. Condition-Specific Vision Supplements Market in 2007
- U.S. Consumer Antioxidant Supplements Market Sales & Growth: 1997-2007
- U.S. Condition-Specific Joint Health Product Sales: 2000-2007
- $937 Million U.S. Condition-Specific Digestive Health Supplements Market in 2007
- U.S. Condition-Specific Diabetes Supplements Market Sales & Growth: 1997-2007
- NBJ Index Stock Summary Tables
- U.S. Nutrition Industry Sales in Mass vs. Natural & Specialty Channels: 1997-2007
- NBJ Price Index
|
COMPANIES INCLUDED:
|
5-Loxin
Accutane
Activia
ActivJoint
Actonel
Adipex
Airborne
Airborne Health
Alka Seltzer
Alli
Ambien
American College of Gastroenterology
American College of Nutrition
American Herbal Products Association
American Journal of Clinical Nutrition
Annals of Internal Medicine
Aquamin
Archives of Internal Medicine
Aricept
Avandia
Bausch & Lomb
Bayer
Bayer Aspirin With Heart Advantage
Bayer Women's Aspirin Plus Calcium
Bextra
BioCor
BioCor Carbo
BioCor Dairy
BioCor Lipo
BioCor Pro
Boniva
Buddy BEAR
Bullwater Health & Fitness
Caltrate
Carill
Celebrex
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Centrum Cardio
Children's Hospital of Los Angeles
Chocolate Pillows
Chromax
ChromeMate
Cialis
Cinnulin PF
Citracal
Citrimax
Claritin
Clinical Products
Cognis Nutrition
Cognizin
Council for Responsible Nutrition
Crestor
Cyvex Nutrition
Dannon
Diabetes Essentials
Diachrome
Diabetes Essentials
DiarEASE
Dreamerz
DSM International
Effexor
EG Labs
Elations
Enzyte
Essential Blend Digestive
Enzymes
Evista
Excelon
Extend Bar
Extend Chips
Federal Register
Fenugreek
FloreBABY
Fosamax
Fosteum
Frutarom
FUZE
Garden of Life Inc
Genuine N-Zime #1
GlaxoSmithKline
GliSODin
GlucoRedux
GlySync
GNC
Groupe Danone
GTC Nutrition
Halls Defense
Harvard University
Health & Wellness Trends Database
Hydroxycut
Imodium
IMS Health
Inegrity Neutraceuticals
Insight North America
Institut Rosell
InsuVital
Intel
InterHealth Nutraceuticals
International Pharmaceuticals
International Probiotics Association (IPA)
Information Resources In.
Jack Distribution
Jigsaw Health
|
JMX-2
Joint Juice Plus
Journal of Inflammation
Journal of the American Medical Association
Juvenon
KidLAX
KidZYME
Kyowa
Hakko USA
LDI Group
Levitra
Lexapro
Libido Max
LifeVantage Corp
Limbrel
Lipitor
Lunesta
Marigot Ltd
May-Pro
McNeil
Medridia
MenaQ7
Metabolife
Metabolism
Miacalcin
MiraLAX laxative
Mucinex
Namenda
National Enzyme Company (NEC)
National Eye Institute
National Institute of Mental Health
National Sleep Foundation (NSF)
Natural Balance
Natural Grocers by Vitamin Cottage
Natural Marketing Institute
New England Journal of Medicine
Nexium
Nicholas Hall & Co
Nielsen
NMI's 2007 Health and Wellness Trends Database
NOP World
Nu Skin Enterprises
Nutrition 21
Nutrition Reviews
Ocuvite
OLAY Vitamins
Oligonol
Organic Smooth Move
ParaGONE
Paxil
Pegasus Captial Advisors
Pennington Biomedical Research Center
Pepsi
Pepto Bismol
PL Thomas
Pomology
Prilosec
Primus
Pharmaceuticals
Probio'Stick
Proctor & Gamble
Promilin
Protandim
Protecflor
Renew Life
Reuters
Ricola
Sambucol
Schering-Plough
Sierra Mountain Minerals
SierraSil
Sirtris Pharmaceuticals
Skinny Water
Slenderize
Sobe
Source Naturals
SPINS
Sunburst Biorganics
SuperCitrimax
Tava
Terry Labs
The Gastro Bundle
The National Institutes of Health
Traditional Medicinals
TSI Health Science
U.S Food and Drug Administration (FDA)
UC-II University of Colorado Health Sciences Center
Viactiv
Viagra
Vioxx
Virmax
Vitamin Shoppe
Vytorin
Walgreens
Wal-Mart
Washington Post
Wyeth
Xangold
Xenical
Yale University
Zenflo
Zetia
Zicam
Zyrtec
| | |
|
Subscribe to NBJ and receive the industry's latest market data & strategic analysis every month. A subscription to NBJ is the equivalent of having your own in-house research deptartment!
Copyright © 2007 Penton Media, Inc.
tel: (303) 998.9399, fax: (303) 385.0046. All rights reserved. This website, or any part, may not be duplicated, stored in a retrieval system or transmitted in any form without prior written permission of the publisher. Unauthorized use of this information is illegal. Disclaimer: Although NBJ has made every effort to be accurate, errors may appear and are unintentional.
|
|
